BioVU Archive — Page 6 of 8

Portrait of Vivian Kawai, MD, MPH, wearing glasses and a white coat over a red shirt.
July 23, 2020

Kawai receives award to accelerate lupus research

Vivian Kawai, MD, MPH, research assistant professor of Medicine, has received an LRA-BMS Accelerator Award from the Lupus Research Alliance and sponsoring partner Bristol Myers Squibb.

Silhouette of a person facing a glowing DNA double helix, overlaid with floating binary digits in a blue-toned digital composition.
April 30, 2020

EHRs, biobanks and Mendelian diseases

Electronic health records and biobanks can be effectively combined to detect and study Mendelian diseases such as cystic fibrosis.

Stylized 3D rendering of a DNA double helix beside a glowing wireframe Earth, overlaid with molecular formulas, binary digits, and scientific graphics.
April 23, 2020

VUMC joins global effort to explore COVID-19 genetics

Vanderbilt University Medical Center investigators have joined an international genetics effort to make advances as quickly as possible on understanding and treating COVID-19.

Side-by-side fluorescent microscopy comparison: larger, regularly shaped healthy cartilage cells on the left and smaller, irregularly shaped cells in the CATIFA model on the right, labeled “Healthy Cartilage Cells” and “CATIFA model Cartilage Cells.”
January 13, 2020

Vanderbilt-led team discovers new genetic disease and defines underlying mechanism

An international research team has discovered a new genetic syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms.

Futuristic blue digital illustration combining a DNA double helix with glowing circuit-board patterns, binary-style numbers, and vertical data streams.
November 19, 2019

Getting the goods on obesity

Obesity and two post-operative complications linked with it have associated genetic variants in common, suggesting that obesity may be the culprit.

Pile of pink, oblong tablets on a white background.
November 6, 2019

Study finds acid reducers may pose risk for children

The use of acid reducers among children is on the rise and so are potential side effects, which is sparking concern according to a recent study.